The perilymphatic space of the guinea pig cochlea was perfused with various concentrations of Ca*+ , Mg=+ and, gentamicin. Cochleae microphonic potentials (CM) were essentially stable when solutions contained 1 mM Ca2+ plus 2 mM Mg'+, 1 mM Ca2+ and no Mg2+ or when both Ca2+ and Mg2+ were omitted, In the absence of Ca2+, the Presence of 2 mM Mg2+ or 1 mM EGTA markedly decreased CM.
Introduction
AminogIycoside antibiotics exert three major toxic actions on mammalian tissues: block of neuromuscular and ganghonic transmission [ 121, nephrotoxicity [S] and otototicity [2] . Each of these effects has its own characteristics and relationships between them are not readily apparent. Antagonism by calcium has been reported for the actions of aminoglycosides at neuromuscular and synaptic junctions f12,17] but not for nephro-and ototoxicity; neuromuscular block and renal damage are reversible while cochlear effects are irreversible and may even progress after cessation of drug treatment.
Studies in the lateral line organ, however, suggest that the ototoxic effects of aminoglycosides are influenced by cations and may be reversible under specific conditions. The suppression of ~cropho~c output by low streptomycin concentrations was reversed by high (#'I while high drug concentrations acted irreversibly 0378~5955/82/0000-OOOOooo/sO2.75 Q 1982 Blsevier Biomedical Press [19] ; the effects of neomycin on afferent synchronization were somewhat mitigated by the addition of 20 mM Ca2+ [ 151; and calcium prevented the action of dihydrostreptomycin on extracellular receptor potentials and the afferent nerve response [7] .
We have previously proposed a hypothesis of aminoglycoside toxicity based on in vivo and in vitro observations. It postulates a biphasic membrane action of the drugs [9, 18] : aminoglycosides first displace membrane calcium in a step that is competitive with calcium and reversible; secondly, they specifically interact with the acidic phospholipid, phosphatidylinositol bisphosphate, a process non-competitive with Ca" and leading to irreversible membrane damage. While the details of this model were delineated primarily from in vitro drug-lipid interactions [9, 14] the hypothesis suggests a sequence of in vivo actions. The present study tests the reversibility and calcium antagonism of gentamicin-induced loss of cochlear microphonics in perilymphatic perfusions .of the guinea pig cochlea.
Materials and Methods
Perilymphatic perfusions were carried out in male albino guinea pigs (200-400 g). Surgical and perfusion techniques were essentially as previously described [8, 11] . An animal with a positive Preyer hearing reflex was anesthetized with pentobarbital(20 mg/kg body wt., i.p.), atropine sulfate (0.05 mg/kg body wt., s.c.) and Innovar (0.5 ml/kg body wt., i.m. containing 0.4 mg fentanyl and 20.0 mg droperidol/ml). Body temperature was maintained at 37 5 1 'C with a heating pad and artificial respiration provided through a tracheal cannula.
Glass capillaries were implanted into the basal turn of Scala tympani and Scala vestibuli. Cochlear microphonic potentials (CM) were measured from an electrode in one of the capillaries in response to a sound stimulus of white noise, 20-4000 Hz, delivered through an earphone. The sound intensity was adjusted to approximately 70 dB SPL to give an initial CM of 200-400 PV (RMS). Perilymphatic spaces were perfused at a rate of approximately 30 pl/min with artificial perilymph containing 130 mM NaCl, 5 mM KCl, 1 mM CaCl,, 2 mM MgCl,, 0.1 mM NaH,PO,, 10 mM NaHCO,, 5 mM glucose and 10 mM Hepes, final pH, 7.4. After CM had stabilized for 30 min the 'control perfusate' was switched to the 'experimental perfusate' containing the drug and the perfusion continued. Experiments were usually carried out for 90-120 min but perfusions without drugs could be extended for up to 3 h without major (c 20%) loss of CM. Animals with an initial CM of less than 200 PV or with an unstable CM during the control period (loss of > 10%) were eliminated from the study.
Results are expressed as initial rate of loss of CM (%/mm) as well as the absolute loss after 30 min of drug perfusion. These two measurements, while yielding essentially similar results, are not identical. The rate of loss, particularly at high drug concentrations, is not necessarily linear for 30 min. Input-output functions of CM before and after perfusion of gentamicin showed that measurements at the chosen fixed intensity were representative of the drug-induced CM loss.
Gentamicin sulfate was a gift from the Schering Corp. (Bloomfield, N.J.).
Results
Prior to testing the aminoglycoside, the effects of the divalent cations Ca2+ and Mg2+ in the artificial perilymph were investigated (Table I ). In the presence of both 1 mM Ca" and 2 mM Mg 2+ CM was essentially stable over the experimental period. Neither the omission of 'Mg2+ nor the simultaneous omission of Ca2+ and Mg 2+ had significa nt effects. However, when Ca2+ was absent from the medium, the presence of Mg2+ or 1 mM EGTA led to a marked decrease of CM. While the actions of Mg2+ and gentamicin (see below) were apparent within a few minutes after reaching the cochlea (delay 3-7 min), the onset of EGTA action was highly variable (delay 6-52 min). Therefore, the apparent loss at 30 min is not a meaningful measure in this case.
The addition of 3 mM gentamicin to the perfusate lowered CM significantly ( Fig.  1 and Table II ). The magnitude of the effect was clearly dependent on the concentration of Ca2+ present, being highest in the absence of Ca2+ . 10 mM Ca2' eliminated the action of gentamicin: a short, initial loss of CM did not persist and CM recovered to reach essentially control values (Fig. 1) . In contrast to the action of Ca2+, Mg 2+ did not antagonize the aminoglycoside action. In the absence of calcium, effects of Mg2+ and drug were additive. For the study of reversibility of gentamicin-induced loss of CM, the drug was first administered with regular artificial perilymph containing 1 mM Ca" and 2 mM Mg . 2+ (Fig 2, point A) . After an initial controlled loss of CM, drug-containing Fig. 2 . Reversibility of genta~cin-induced suppression of cochlear microphonic potentials. Pe~lymphatic perfusions were carried out as described in Materials and Methods. Following the control perfusion (O-30 min), the perfusate was changed a first time at point A to experimental perfusate containing gentamicin, a second time at point I3 to wash perfusate without drug; in one series of experiments, a third change was made at point C. The variations of artificial perilymph were: -, 3 mM gentamicin at A, 10 mM CaCl, at B; -e-, 3 mM gentamicin at A, no additions at B, 10 mM CaCl, at C; ---, 10 mM gentamicin at A, 10 mM CaCl, at B. Note that 'artificial perilymph' always contains 1 mM CaCl,. Curves show typical experimental results.
TABLE III REVERSIBILITY OF LOSS OF COCHLEAR MICROPHONICS
Cochlear perfusions were carried out as described in Materials and Methods, and Results. Control perfusate (1 mM Ca 2+, 2 mM Mg*+ ) was perfused for 30 min. followed by perfusion with experimental medium (see also Fig. 2, point A) which was subsequently exchanged for the 'wash' perfusate (Fig. 2, point  8) . Rate of loss (%/min) refers to initial rate (see Materials and Methods); minimum of CM refers to the minimum of CM during the experiment before reversal of slope. When no minimum was apparent (i.e. no recovery under the conditions 3 mM Gm/l mM Cazf or 10 mM Gm) the value refers to CM at the change of slope induced by the wash. Numbers are means * S.D., with number of animals given (n) in the last column.
Additions to [Ca2+ ] Differs from control (paired r-test): P <O.Ol. ** Differs from ~nimum CM: P (0.01. *** Differs from minimum CM: P ~0.035. 'experimental perfusate' was exchanged for a drug-free 'wash perfusate' with varying calcium concentrations (Fig. 2, point B) . When gentamicin was administered at 3 mM, followed by wash perfusate with 1 mM Ca2+, loss of CM continued after elimination of the drug from the cochlea, albeit a change to a lesser loss per min after 5 min (Fig. 2, Table III) ; final subsequent perfusion with 10 mM Ca2+ in perilymph (Fig. 2, point C) did not recover CM. In contrast, when 10 mM Ca2' was perfused immediately following 3 mM gentamicin (Fig. 2, point B) CM recovered to control values within about 40 min. Such reversibility by 10 mM Ca2+ was not observed when the initial drug concentration was raised to 10 mM gentamicin. The detrimental effects of 10 mM Mg2+ or 1 mM EGTA on CM could be reversed, at least partially, by 10 mM Ca2+ (TableIII). [9, 14, 18] . Secondly, a perfusion with 10 mM Ca2+ is effective in restoring CM if directly applied after exposure of the cochlea to 3 mM gentamicin. However, after longer exposures or higher concentrations of the drug, reversibility can no longer be observed. High calcium (10 mM) failed to reverse the drug effect when its application was delayed by 60 min, although the cochlea was washed free of excess drug during this time by artificial perilymph containing 1 mM Ca'+. Similarly, calcium antagonism is no longer observed when gentamicin is raised to 10 mM.
Our demonstration of the biphasic ototoxic action of gentamicin has both theoretical and clinical implications. It is clearly consistent with and supports our previous hypothesis of a two-step or biphasic action of aminoglycosides. The initial displacement of calcium and concomitant inhibition of membrane function are reversible. The second step, postulated to be a specific interaction with a receptor like phosphatidylinositol bisphosphate, is non-competitive with Ca2+ and essentially irreversible [ 141.
Of potential clinical importance is the observation that aminoglycoside ototoxicity is initially reversible. In practice, however, means to manipulate calcium levels in the inner ear are limited. Juhn reported [4] only transiently increased perilymphatic Ca2+ following hyp ercalcemia induced by CaCl, injections in chinchillas. Generally, cochlear calcium concentrations follow serum concentrations which are under homeostatic control. Increased calcium loads are efficiently excreted by the kidney. Also, it has to be considered that an antagonism by calcium will not only be directed against the toxic effects of aminoglycosides but also against their antibacterial efficacy [I] .
Drug concentrations in these model studies are higher than those expected in the cochlea after application of clinically relevant doses (0.01-0.1 mM, Tran Ba Huy and Schacht, in preparation). The fact that 1 mM Ca2+, the approximate concentration in serum and perilymph, is rather ineffective in suppressing aminoglycoside damage in perfusions should therefore not lead to false conclusions. Physiological concentrations of calcium may well be effective antagonists of aminoglycosides in vivo until time of exposure or concentration of drug reach a certain limit. It would be of interest to determine this limit in viva.
In summary, our study shows that initial gentamicin actions on the guinea pig cochlea are reversible by calcium, similarly to those at the neuromuscular junction and kidney.' Depending on duration and concentration of the drug, irreversible damage will follow in the cochlea.
